Victoria Pratt, PhD
Professor of Clinical Medical & Molecular Genetics
Dr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory and Molecular Genetics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.
In addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC’s GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the National Academies (formerly Institute of Medicine)’s Roundtable on Genomics and Precision Health. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC) and the Institute of Medicine/National Academy of Medicine’s Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies.
Dr. Pratt is Past Chair of the Genetics, Clinical Practice and the Program committees and is currently a member of the Economic Affairs Professional Relations committees for the Association of Molecular Pathology. Dr. Pratt has been elected President of AMP and her 1-year term will start Nov. 2018. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association’s (AMA’s) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.
Dr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.
Titles & Appointments
- Director, Pharmacogenomics and Molecular Genetics Laboratories
Indiana University Institutional Review Board (IRB-02) Member, 2016. American Medical Association (AMA) Current Procedural Terminology (CPT) CodingPLA Technical Advisor, 2016. Center for Medicare and Medicaid Services, Advisory Panel Member on Clinical Diagnostic Laboratory Tests, 2015 National Academy of Medicine/Institute of Medicine (IOM) Committee Member on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, 2015 American Medical Association (AMA) Current Procedural Terminology (CPT) Coding CodeBridge Advisor, 2014-2016. Reviewer for Clinical Chemistry and Laboratory Medicine (CCLM), 2013. American Medical Association (AMA) Current Procedural Terminology (CPT) Coding Molecular Pathology Advisor (MPAG), 2012-present. Board Member of the Institute of Medicine (IOM)/National Academy of Medicine Roundtable Genomics and Precision Health, 2011-present Representative on the Task Force of Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) Carrier Screening Workgroup, 2011-2013 Associate Editor for the Journal of Molecular Diagnostics, 2010-present <span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New R
American Medical Association (AMA)
Association of Molecular Pathologists (AMP)